Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver

Pediatric Blood and Cancer

Volumn 50, Issue 6, 2008, Pages 1280-1281

  Zidan, Hanaa ^a   Lo, Stanley ^a   Wiebe, Donald ^b   Talano, Julie ^a   Alemzadeh, Ramin ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Graft versus host disease; Hypercholesterolemia; Hyperlipidemia; Lipoprotein X

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CHOLESTEROL; ESCITALOPRAM; FISH OIL; LIPOPROTEIN X; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PENTAMIDINE; TACROLIMUS; TRIACYLGLYCEROL;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BILE REFLUX; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPERCHOLESTEROLEMIA; LIVER DISEASE; OBSTRUCTIVE JAUNDICE; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

BILE REFLUX; CHILD; CHOLESTASIS, INTRAHEPATIC; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN-X;

EID: 42349086297     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21522     Document Type: Article

References (21)

1. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients. Am J Cardiol 1984;54:20-30.
2. Connelly PW, Hegele RA. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998;35:547-572.
3. McIntyre N, Harry DS, Pearson AJG. The hypercholesterolemia of obstructive jaundice. Gut 1975;16:379-391.
4. Dickson ER, Fleming CR, Ludwig J. Primary biliary cirrhosis. In: Popper H, Schaffner F, editors. Progress in liver diseases, Vol. 6. New York: Grune & Stratton; 1979. pp. 487-528.
5. Coetzee GA, van der Westhuyzen DR, Berger GM, et al. Low-density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia. Arteriosclerosis 1982;2:303-311.
6. Rosenson RS, Baker AL, Chow MJ, et al. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990;98:1351-1357.
7. Toren A, Nagler A. Solitary pulmonary cholesteroloma, multiple xanthelasmas, lipemia retinalis complicating hypercholesterolemia after bone marrow transplantation. Bone Marrow Transplant 1996;18:457-459.
8. Illingworth DR. How effective is drug therapy in heterozygous familial hypercholesterolemia? Am J Cardiol 1993;72:54D-58D.
9. Malloy MJ, Kane JP, Kunitake ST, et al. Complementarity of colestipol, niacin, lovastatin in treatment of severe familial hypercholesterolemia. Ann Intern Med 1987;107:616-623.
10. Gordon BR, Kelsey SF, Bilheimer DW, et al. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group. Am J Cardiol 1992;70:1010-1016.
11. Neudorf S, Sanders J, Kobrinsky N, et al. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 2004;103:3655-3661.
12. Coakley JC, Vervaart PP, McKay MRG. Factitious hyponatremia in a patient with cholestatic jaundice following bone marrow transplantation. Pathology 1986;18:158-159.
13. Turrchin A, Wiebe DA, Seely EW, et al. Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of liver. Bone Marrow Transplant 2005;35: 85-89.
14. Kuster GM, Drexel H, Bleisch JA, et al. Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 1994;57:1479-1483.
15. Satterthwaite R, Aswad S, Sunga V, et al. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation 1998;65:446-449.
16. Chueh SC, Kahan BD. Dyslipidemia in renal transplant recipients treated with a sirolimus, cyclosporine-based immunosuppressive regimen: Incidence, risk factors, progression, and prognosis. Transplantation 2003;76:375-382.
17. Morrisett JD, Abdel-Fattah G, Hoogeveen R, et al. Effects of sirolimus on plasma lipids, lipoprotein levels, fatty acid metabolism in renal transplant patients. J Lipid Res 2002;43:1170-1180.
18. Roche Laboratories. Cellcept® (mycophenolate mofetil) Complete Product Information (online), 2004 (cited October 14, 2004). Available from http://www.rochusa.com/products/cellcept/pi.pdf.
19. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 2000;16:505-511.
20. O'Brien T, Dinneen SF, O'Brien PC, et al. Hyperlipidemia in patients with primary, secondary hypothyroidism. Mayo Clin Proc 1993;68:860-866.
21. Glomset JA, Nichols AV, Norum KR, et al. Plasma lipoproteins in familial lecithin-cholesterol acyltransferase deficiency. J Clin Invest 1973;52:1078-1092.